Your browser doesn't support javascript.
loading
Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T).
Brown, Kevin; Seftel, Matthew D; Hay, Kevin A.
Afiliação
  • Brown K; Leukemia and Bone Marrow Transplant Program of British Columbia (Hay); Division of Hematology, Department of Medicine (Seftel, Hay), University of British Columbia; Canadian Blood Services (Seftel); Terry Fox Laboratory (Hay), British Columbia Cancer Research Institute, Vancouver, BC; Department of Internal Medicine (Brown), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.
  • Seftel MD; Leukemia and Bone Marrow Transplant Program of British Columbia (Hay); Division of Hematology, Department of Medicine (Seftel, Hay), University of British Columbia; Canadian Blood Services (Seftel); Terry Fox Laboratory (Hay), British Columbia Cancer Research Institute, Vancouver, BC; Department of Internal Medicine (Brown), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man.
  • Hay KA; Leukemia and Bone Marrow Transplant Program of British Columbia (Hay); Division of Hematology, Department of Medicine (Seftel, Hay), University of British Columbia; Canadian Blood Services (Seftel); Terry Fox Laboratory (Hay), British Columbia Cancer Research Institute, Vancouver, BC; Department of Internal Medicine (Brown), Max Rady College of Medicine, University of Manitoba, Winnipeg, Man. khay@bccrc.ca.
CMAJ ; 193(33): E1300-E1302, 2021 08 23.
Article em En | MEDLINE | ID: mdl-34426446

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Imunoterapia Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Imunoterapia Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article